跳至主要内容
临床试验/RBR-5kyg2r
RBR-5kyg2r已完成未知

Effectiveness of intralesional Betametasone versus Triancinolone Acetonide in the treatment of Alopecia Areata

niversidade Federal do Ceará, Campus Sobral0 个研究点开始时间: 2020年5月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 60Y(—)

入选标准

  • both genders; age between 18 and 60 years; clinical diagnosis of localized alopecia areata, with less than 25% area of hair loss; presence of an alopecia patch with a larger diameter between 2 and 5 cm

排除标准

  • any form of therapy for alopecia areata in the past 3 months; use of systemic corticosteroids or immunosuppressive drugs; illness or condition that causes immunosuppression; rapidly progressive disease; presence of another cause of alopecia; presence of an inflammatory process in the alopecia patch; history of allergy to corticosteroids; pregnancy or lactation

研究者

发起方
niversidade Federal do Ceará, Campus Sobral

相似试验